Dr Frenkel-Morgenstern of Israel’s Bar-Ilan University has filed a US patent application for her research (see previously) on epitopes (proteins) that can build immunity against COVID-19. An advantage of such a vaccine is it will still work even if the virus mutates.
Developing a mutation-proof Covid-19 vaccine
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.